By
A study conducted by Israeli researchers in Haifa showed the short-term effectiveness and safety of micro doses of medical cannabis administered via a metered-dose inhaler (the Syqe Inhaler) in chronic pain patients, according to data published in the journal Pain Reports.
“The administration of aerosolized cannabis through an inhaler may reduce long-term pain in patients with neuropathy and other chronic conditions,” researchers said. The daily stable dose investigators used for their patients was 1.5 mg of aerosolized delta-9-THC.
RELATED: another recent study found that some orally ingested cannabis products can provide short-term relief from chronic pain. The study notes that high ratios of tetrahydrocannabinol (THC) to cannabidiol (CBD) also may reduce significant pain in patients.
A study recently published in the Annals of Internal Medicine demonstrated that medical cannabis program enrollment jumped over four times between 2016 and 2020, reaching nearly three million patients in 2020.
This article originally appeared on Benzinga and has been reposted with permission.
